Find out more about the challenges in pre- and post-release stability testing and formulation. This interview explores the technologies being employed by Lifecycle Pharma to pre-empt these. Claire Willsher, head of analytical development at Lifecycle Pharma, Willsher also offers her perspective on Quality by Design, cost-cutting and how to achieve regulatory compliance
Pharma IQ | 08/02/2010
RECOMMENDED
MSD announces Phase III data on investigational treatment to lower LDL Cholesterol (LDL-C)
2025-11-17
AI for Pharma & Healthcare 2025
2025-06-18
Upcoming Events
Pharma Contract Manufacturing
23 - 25 March 2026
Mercure Hotel MOA Berlin, Germany
Register Now |
View Agenda |
Learn More